Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

v3.21.1
NET LOSS PER SHARE (Tables)
3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Schedule of antidilutive securities excluded from computation of earnings per share
The following common stock equivalents were not included in the calculation of net loss per diluted share because their effect were anti-dilutive (in thousands):
Three months ended March 31,
2021 2020
Stock options 25,547  20,535 
Performance stock options 5,000  5,000 
Total 30,547  25,535